Through the activation of 5′-adenosine monophosphate-activated protein kinase (AMPK), metformin inhibits the expression of mammalian target of rapamycin (mTOR), which in turn prevents cell aging and cancer development [48-50]. This evidence concerns the gene MTOR and cancer.